GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ChemoMetec AS (OCSE:CHEMM) » Definitions » Price-to-Owner-Earnings

ChemoMetec AS (OCSE:CHEMM) Price-to-Owner-Earnings : 77.91 (As of May. 15, 2025)


View and export this data going back to 2006. Start your Free Trial

What is ChemoMetec AS Price-to-Owner-Earnings?

As of today (2025-05-15), ChemoMetec AS's share price is kr498.60. ChemoMetec AS's Owner Earnings per Share (TTM) ended in Jun. 2024 was kr6.40. It's Price-to-Owner-Earnings for today is 77.91.


The historical rank and industry rank for ChemoMetec AS's Price-to-Owner-Earnings or its related term are showing as below:

OCSE:CHEMM' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 33.68   Med: 100.98   Max: 274.22
Current: 76.55

During the past 13 years, the highest Price-to-Owner-Earnings of ChemoMetec AS was 274.22. The lowest was 33.68. And the median was 100.98.


OCSE:CHEMM's Price-to-Owner-Earnings is ranked worse than
79.31% of 290 companies
in the Medical Devices & Instruments industry
Industry Median: 29.11 vs OCSE:CHEMM: 76.55

As of today (2025-05-15), ChemoMetec AS's share price is kr498.60. ChemoMetec AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was kr9.72. Therefore, ChemoMetec AS's PE Ratio (TTM) for today is 51.30.

As of today (2025-05-15), ChemoMetec AS's share price is kr498.60. ChemoMetec AS's EPS without NRI for the trailing twelve months (TTM) ended in was kr9.72. Therefore, ChemoMetec AS's PE Ratio without NRI for today is 51.30.

During the past 13 years, ChemoMetec AS's highest PE Ratio without NRI was 248.57. The lowest was 25.54. And the median was 70.12.


ChemoMetec AS Price-to-Owner-Earnings Historical Data

The historical data trend for ChemoMetec AS's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChemoMetec AS Price-to-Owner-Earnings Chart

ChemoMetec AS Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 103.08 174.13 90.81 59.81 47.59

ChemoMetec AS Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 59.81 - 47.59 -

Competitive Comparison of ChemoMetec AS's Price-to-Owner-Earnings

For the Medical Devices subindustry, ChemoMetec AS's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ChemoMetec AS's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ChemoMetec AS's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where ChemoMetec AS's Price-to-Owner-Earnings falls into.


;
;

ChemoMetec AS Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

ChemoMetec AS's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=498.60/6.40
=77.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ChemoMetec AS  (OCSE:CHEMM) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


ChemoMetec AS Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of ChemoMetec AS's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


ChemoMetec AS Business Description

Traded in Other Exchanges
Address
Gydevang 43, Allerod, DNK, 3450
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.

ChemoMetec AS Headlines

No Headlines